Figure 3: Benefit with high vs. low dose ACE inhibitor on top of beta-blocker therapy.
Point estimates of relative risk and 95% confidence intervals in the two angiotensin-converting enzyme inhibitor dose groups for various outcomes.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.